http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#head http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#assertion http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#provenance http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#publicationInfo http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#assertion http://bio2rdf.org/drugbank:DB00238 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00238_DB01072 http://bio2rdf.org/drugbank:DB01072 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00238_DB01072 http://bio2rdf.org/drugbank_resource:DB00238_DB01072 http://purl.org/dc/terms/identifier drugbank_resource:DB00238_DB01072 http://bio2rdf.org/drugbank_resource:DB00238_DB01072 http://purl.org/dc/terms/title DDI between Nevirapine and Atazanavir - Nevirapine, a strong CYP3A4 inducer, may decrease the serum concentration of atazanavir by increasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of atazanavir if nevirapine is initiated, discontinued or dose changed. http://bio2rdf.org/drugbank_resource:DB00238_DB01072 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00238_DB01072 http://www.w3.org/2000/01/rdf-schema#label DDI between Nevirapine and Atazanavir - Nevirapine, a strong CYP3A4 inducer, may decrease the serum concentration of atazanavir by increasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of atazanavir if nevirapine is initiated, discontinued or dose changed. [drugbank_resource:DB00238_DB01072] http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#provenance http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#publicationInfo http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#signature.MCwCFD1nZ_6Zgeo- http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#signature.MCwCFD1nZ_6Zgeo- http://purl.org/nanopub/x/hasSignature MCwCFD1nZ/6Zgeo+LUSLRdVaY1qv13wSAhR0VxYRuRJTj3wB5ay2f44EMkMU4g== http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#signature.MCwCFD1nZ_6Zgeo- http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs http://purl.org/dc/terms/created 2018-03-30T11:12:50.320+02:00 http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs#signature.MCwCFD1nZ_6Zgeo- http://bio2rdf.org/drugbank_resource:DB00238_DB01072_nanopub.RAoFKIBNSEiGHx0VpPv8cYF4IepEQLQfAHznYZXxxprCs http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234